TrialPanorama/TrialPanorama-database huggingface dataset:
Study 19621678 — Predictive Biomarker (PRD): MLH1 mRNA
Genes: MLH1; COCA2
Study 19621678 — Predictive Biomarker (PRD): DNA mismatch repair protein MSH2
Genes: MSH2
Study 19621678 — Predictive Biomarker (PRD): Microsatellite instability
Study 11171785 — Predictive Biomarker (PRD): HES1 mRNA
Genes: HES1; BHLHB39; HL; HRY
Study 29310611 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 30178473 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 26731173 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 11922259 — Surrogate Endpoint (SUR): Bone mineral density
Study 9849707 — Surrogate Endpoint (SUR): Bone mineral density
Study 27354031 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 11158455 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 2102029 — Surrogate Endpoint (SUR): Serum uric acid
Study 939029 — Surrogate Endpoint (SUR): Blood pressure
Study 25728015 — Surrogate Endpoint (SUR): Blood pressure
Study 3236382 — Surrogate Endpoint (SUR): Blood pressure
Study 25178692 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 12538778 — Predictive Biomarker (PRD): ABR mRNA
Genes: ABR
Study 8752181 — Predictive Biomarker (PRD): LAD1 mRNA
Genes: LAD1; LAD
Study 1460163 — Predictive Biomarker (PRD): CORT mRNA
Genes: CORT; UNQ307/PRO350
Study 1460163 — Predictive Biomarker (PRD): PBX1 mRNA
Genes: PBX1; PRL
Study 30676094 — Safety Biomarker (SAF): Reactive oxygen species
Study 30650291 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study 12560354 — Safety Biomarker (SAF): MTHFR
Study 7791169 — Surrogate Endpoint (SUR): Serum creatinine
Study 2289220 — Surrogate Endpoint (SUR): Forced vital capacity
Study 31255504 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 10972631 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 26352063 — Predictive Biomarker (PRD): TTN mRNA
Genes: TTN
Study 16412324 — Predictive Biomarker (PRD): SRY mRNA
Genes: SRY; TDF
Study 16412324 — Predictive Biomarker (PRD): MFSD11 mRNA
Genes: MFSD11; ET
Study 29367197 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 29367197 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 29367197 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 29367197 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 29367197 — Monitoring Biomarker (MOI): Cell-free DNA
Study 26589368 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 26589368 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 24706353 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 24706353 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 23964445 — Surrogate Endpoint (SUR): Blood pressure
Study 7045365 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 25682436 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 23066159 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 9809088 — Surrogate Endpoint (SUR): Blood pressure
Study 7544439 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study 31594858 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study 28246176 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 24565127 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 24565127 — Surrogate Endpoint (SUR): Blood pressure
Study 17966842 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study 17966842 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 9534083 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 9534083 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 22025233 — Surrogate Endpoint (SUR): Blood pressure
Study 18458360 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 18458360 — Predictive Biomarker (PRD): CFH mRNA
Genes: CFH; HF; HF1; HF2
Study 22402472 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 22402472 — Surrogate Endpoint (SUR): Blood pressure
Study 20304805 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study 20304805 — Predictive Biomarker (PRD): MPL mRNA
Genes: MPL; TPOR
Study 16476804 — Surrogate Endpoint (SUR): Blood pressure
Study 2409325 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 29498170 — Predictive Biomarker (PRD): DBH mRNA
Genes: DBH
Study 27920083 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 27920083 — Surrogate Endpoint (SUR): Blood pressure
Study 22790645 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study 25948781 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 8306514 — Surrogate Endpoint (SUR): Blood pressure
Study 3028596 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAV1 mRNA
Genes: CAV1; CAV
Study 22088980 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 16046076 — Surrogate Endpoint (SUR): Blood pressure
Study 1286181 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 1286181 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 30046828 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 30046828 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 8063650 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 8063650 — Surrogate Endpoint (SUR): Blood pressure
Study 23391421 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 23391421 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 23391421 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 23391421 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study 21573977 — Safety Biomarker (SAF): Ornithine transcarbamylase
Genes: OTC
Study 28653239 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study 12360153 — Predictive Biomarker (PRD): ACAT1 mRNA
Genes: ACAT1; ACAT; MAT
Study 30573355 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study 27776459 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 27776459 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 2837300 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 2837300 — Surrogate Endpoint (SUR): Blood pressure
Study 23997711 — Predictive Biomarker (PRD): MXD1 mRNA
Genes: MXD1; MAD
Study 23997711 — Surrogate Endpoint (SUR): Blood pressure
Study 16314615 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3
Study 12846491 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 12846491 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 31702684 — Predictive Biomarker (PRD): DCD mRNA
Genes: DCD; AIDD; DSEP
Study 25782660 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 23280432 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 21885491 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 12692541 — Predictive Biomarker (PRD): FUT2 mRNA
Genes: FUT2; SEC2
Study 7788003 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 7788003 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 2195937 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study 29118299 — Predictive Biomarker (PRD): TAT mRNA
Genes: TAT
Study 22569355 — Surrogate Endpoint (SUR): Serum creatinine
Study 17803575 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 11952478 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 11952478 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 11952478 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 2645756 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 2645756 — Surrogate Endpoint (SUR): Blood pressure
Study 2645756 — Surrogate Endpoint (SUR): Serum potassium
Study 21875678 — Safety Biomarker (SAF): Hyaluronic acid
Study 17201083 — Predictive Biomarker (PRD): FHL5 mRNA
Genes: FHL5; ACT
Study 1913759 — Surrogate Endpoint (SUR): Blood pressure
Study 6814225 — Surrogate Endpoint (SUR): Blood pressure
Study 26377322 — Predictive Biomarker (PRD): CPQ mRNA
Genes: CPQ; LCH1; PGCP
Study 15208206 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 24176436 — Surrogate Endpoint (SUR): Blood pressure
Study 17257782 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 10467322 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 8751023 — Surrogate Endpoint (SUR): Blood pressure
Study 25457902 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 1316404 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 1316404 — Surrogate Endpoint (SUR): Blood pressure
Study 28361971 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study 28361971 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 28361971 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 28361971 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 17111319 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 17111319 — Predictive Biomarker (PRD): CFH mRNA
Genes: CFH; HF; HF1; HF2
Study 23448278 — Predictive Biomarker (PRD): CCR4 mRNA
Genes: CCR4; CMKBR4
Study 23448278 — Predictive Biomarker (PRD): CCL17 mRNA
Genes: CCL17; SCYA17; TARC
Study 18353720 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study 10869261 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 2580694 — Predictive Biomarker (PRD): EBPL mRNA
Genes: EBPL; EBRP; ERP
Study 22709755 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 7814484 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 29400990 — Surrogate Endpoint (SUR): Forced vital capacity
Study 28611235 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study 28611235 — Predictive Biomarker (PRD): SCT mRNA
Genes: SCT
Study 21901266 — Predictive Biomarker (PRD): HSPB1 mRNA
Genes: HSPB1; HSP27; HSP28
Study 9839627 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 9839627 — Safety Biomarker (SAF): Hyaluronic acid
Study 2520633 — Surrogate Endpoint (SUR): Blood pressure
Study 23816952 — Surrogate Endpoint (SUR): Blood pressure
Study 17005526 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 17005526 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study 15021447 — Predictive Biomarker (PRD): SERPINA7 mRNA
Genes: SERPINA7; TBG
Study 15021447 — Predictive Biomarker (PRD): RALA mRNA
Genes: RALA; RAL
Study 15021447 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 11710752 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 31087825 — Predictive Biomarker (PRD): PPP1R9B mRNA
Genes: PPP1R9B; PPP1R6
Study 24916903 — Predictive Biomarker (PRD): DLG4 mRNA
Genes: DLG4; PSD95
Study 24916903 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 18409186 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 18409186 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 30854694 — Safety Biomarker (SAF): Hemoglobin scavenger receptor
Genes: CD163; M130
Study 16224147 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 12362542 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 26102724 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 26102724 — Surrogate Endpoint (SUR): Blood pressure
Study 15158606 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 18487901 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study 16822626 — Predictive Biomarker (PRD): GPT mRNA
Genes: GPT; AAT1; GPT1
Study 15298339 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 15298339 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SLC2A4 mRNA
Genes: SLC2A4; GLUT4
Study 11204933 — Surrogate Endpoint (SUR): Blood pressure
Study 27683100 — Predictive Biomarker (PRD): ETV6 mRNA
Genes: ETV6; TEL; TEL1
Study 27683100 — Predictive Biomarker (PRD): RUNX1 mRNA
Genes: RUNX1; AML1; CBFA2
Study 9440475 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 18224563 — Monitoring Biomarker (MOI): Tissue transglutaminase
Genes: TGM2
Study 16998452 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 12729085 — Predictive Biomarker (PRD): ARC mRNA
Genes: ARC; KIAA0278
Study 24519386 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 20945945 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study 10870655 — Safety Biomarker (SAF): Hyaluronic acid
Study 8692118 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 25511777 — Safety Biomarker (SAF): Reactive oxygen species
Study 20185862 — Predictive Biomarker (PRD): CCS mRNA
Genes: CCS
Study 20185862 — Surrogate Endpoint (SUR): Blood pressure
Study 8726246 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 23775701 — Surrogate Endpoint (SUR): Bone mineral density
Study 22828718 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 15163472 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 15163472 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 11334767 — Surrogate Endpoint (SUR): Blood pressure
Study 2832173 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 2832173 — Surrogate Endpoint (SUR): Blood pressure
Study 27942799 — Predictive Biomarker (PRD): SIT1 mRNA
Genes: SIT1; SIT
Study 20860641 — Surrogate Endpoint (SUR): Blood pressure
Study 16455626 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study 14514236 — Predictive Biomarker (PRD): SPTB mRNA
Genes: SPTB; SPTB1
Study 1497054 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 30243898 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 30243898 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 27227930 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study 10232636 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 29543617 — Safety Biomarker (SAF): Hyaluronic acid
Study 19083486 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 16545010 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 8269792 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 8269792 — Surrogate Endpoint (SUR): Blood pressure
Study 21645443 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study 16598319 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 16598319 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 18355134 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 18355134 — Surrogate Endpoint (SUR): Blood pressure
Study 31790905 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 21319354 — Monitoring Biomarker (MOI): Heme oxygenase 1
Genes: HMOX1; HO; HO1
Study 21319354 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 21319354 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 19101790 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 16879516 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 16879516 — Surrogate Endpoint (SUR): Blood pressure
Study 22619366 — Monitoring Biomarker (MOI): Tissue transglutaminase
Genes: TGM2
Study 26767971 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 26767971 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 26767971 — Safety Biomarker (SAF): IL-6 and IL-10
Study 22278425 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 22278425 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 17640790 — Predictive Biomarker (PRD): MAOB mRNA
Genes: MAOB
Study 7744989 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 2033780 — Surrogate Endpoint (SUR): Blood pressure
Study 7305036 — Surrogate Endpoint (SUR): Blood pressure
Study 28503781 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study 28503781 — Predictive Biomarker (PRD): SLCO1A2 mRNA
Genes: SLCO1A2; OATP; OATP1; OATP1A2; SLC21A3
Study 28503781 — Predictive Biomarker (PRD): JAK1
Genes: JAK1A; JTK3
Study 21401909 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 12607857 — Predictive Biomarker (PRD): TBP mRNA
Genes: TBP; GTF2D1; TF2D; TFIID
Study 9208536 — Surrogate Endpoint (SUR): Serum testosterone
Study 3481821 — Surrogate Endpoint (SUR): Blood pressure
Study 19841156 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 11844946 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study 25328284 — Predictive Biomarker (PRD): CD68 mRNA
Genes: CD68
Study 20828223 — Surrogate Endpoint (SUR): Blood pressure
Study 25847558 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 15134386 — Predictive Biomarker (PRD): LYST mRNA
Genes: LYST; CHS; CHS1
Study 11822472 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 11822472 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study 8043891 — Surrogate Endpoint (SUR): Blood pressure
Study 2462651 — Predictive Biomarker (PRD): REG3A mRNA
Genes: REG3A; HIP; PAP; PAP1
Study 25377507 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 25377507 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 21600163 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 21600163 — Surrogate Endpoint (SUR): Blood pressure
Study 10716135 — Surrogate Endpoint (SUR): Blood pressure
Study 9178399 — Surrogate Endpoint (SUR): Serum creatinine
Study 1283198 — Surrogate Endpoint (SUR): Serum sodium
Study 29802443 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study 10596917 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 1714948 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study 26265232 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 17132823 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 21679323 — Surrogate Endpoint (SUR): Blood pressure
Study 19494809 — Predictive Biomarker (PRD): UGT2B7 mRNA
Genes: UGT2B7; UGTB2B9
Study 19494809 — Predictive Biomarker (PRD): ABCC2 mRNA
Genes: ABCC2; CMOAT; CMOAT1; CMRP; MRP2
Study 16461866 — Predictive Biomarker (PRD): VCP mRNA
Genes: VCP
Study 26796355 — Surrogate Endpoint (SUR): Blood pressure
Study 18581464 — Surrogate Endpoint (SUR): Blood pressure
Study 31717971 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 29941516 — Surrogate Endpoint (SUR): Blood pressure
Study 16056171 — Surrogate Endpoint (SUR): Bone mineral density
Study 26728364 — Predictive Biomarker (PRD): MARS1 mRNA
Genes: MARS1; MARS
Study 20650600 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 15109191 — Surrogate Endpoint (SUR): Blood pressure
Study 29112591 — Surrogate Endpoint (SUR): Blood pressure
Study 376132 — Predictive Biomarker (PRD): MERTK mRNA
Genes: MERTK; MER
Study 24089075 — Predictive Biomarker (PRD): MPG mRNA
Genes: MPG; AAG; ANPG; MID1
Study 19079316 — Predictive Biomarker (PRD): SCT mRNA
Genes: SCT
Study 11192306 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 11192306 — Surrogate Endpoint (SUR): Blood pressure
Study 25984808 — Predictive Biomarker (PRD): DCD mRNA
Genes: DCD; AIDD; DSEP
Study 15361500 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 15361500 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 31687079 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 23260750 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 21785346 — Surrogate Endpoint (SUR): Serum creatinine
Study 30356126 — Predictive Biomarker (PRD): L1CAM mRNA
Genes: L1CAM; CAML1; MIC5
Study 30356126 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 20234364 — Surrogate Endpoint (SUR): Pathological complete response
Study 11185667 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 2871007 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 18610754 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 12911137 — Surrogate Endpoint (SUR): Serum potassium
Study 29361433 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 24723487 — Predictive Biomarker (PRD): IK mRNA
Genes: IK; RED; RER
Study 21558573 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 21558573 — Safety Biomarker (SAF): IL-6 and IL-10
Study 20470281 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 20470281 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 12206010 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 3903734 — Surrogate Endpoint (SUR): Blood pressure
Study 24216257 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22767646 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study 16054520 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 19229978 — Predictive Biomarker (PRD): PRF1
Genes: PFP; P1; HPLH2
Study 15102867 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study 7783654 — Predictive Biomarker (PRD): LPL mRNA
Genes: LPL; LIPD
Study 2295294 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study 12297170 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer